ArticleCost effectiveness and resource allocation : C/E2022

Cost utility and budget impact analysis of dexamethasone compared with bortezomib and lenalidomide for the treatment of second line multiple myeloma from a South African public health perspective.

Lineo Marie Matsela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.